LongBio Pharma (Suzhou) Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	0.27	0.27	-1.35	-1.63
Net Debt / Equity Ratio	-1.08	-1.08	-1.03	-1.02
Net Debt / EBITDA Ratio	0.95	0.95	-3.22	-2.51
Net Debt / FCF Ratio	1.22	1.22	-3.09	-3.12
Quick Ratio	2.29	2.29	1.13	1.98
Current Ratio	2.42	2.42	1.30	2.05
Return on Assets (ROA)	-54.56%	-54.56%	-46.45%	-
Return on Capital Employed (ROCE)	-114.00%	-114.00%	-201.90%	-96.70%
Buyback Yield / Dilution	-	-19.32%	-10.91%	-